Joint ENGOT and GOG Foundation requirements for trials with industry partners

European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc

doi:10.1136/ijgc-2019-000441

Joint ENGOT and GOG Foundation requirements for trials with industry partners

European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1094-1097
Number of pages	4
Journal	International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Volume	29
Issue number	7
DOIs	https://doi.org/10.1136/ijgc-2019-000441
Publication status	Published - Sept 2019

Keywords

Biomedical Research/standards
Clinical Trials as Topic/economics
Drug Industry/economics
Female
Genital Neoplasms, Female/drug therapy
Gynecology/economics
Humans
Industry/economics
Medical Oncology/economics

Access to Document

10.1136/ijgc-2019-000441

Cite this

Joint ENGOT and GOG Foundation requirements for trials with industry partners. / European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc.

In: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 29, No. 7, 09.2019, p. 1094-1097.

Research output: Contribution to journal › Article › peer-review

European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc 2019, 'Joint ENGOT and GOG Foundation requirements for trials with industry partners', International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, vol. 29, no. 7, pp. 1094-1097. https://doi.org/10.1136/ijgc-2019-000441

@article{1f675f2dcc604253b06cff7f87f2ceae,

title = "Joint ENGOT and GOG Foundation requirements for trials with industry partners",

keywords = "Biomedical Research/standards, Clinical Trials as Topic/economics, Drug Industry/economics, Female, Genital Neoplasms, Female/drug therapy, Gynecology/economics, Humans, Industry/economics, Medical Oncology/economics",

author = "{European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc} and Ignace Vergote and Coleman, {Robert L} and Sandro Pignata and Bookman, {Michael A} and Christian Marth and Herzog, {Thomas J} and {Gonzalez Martin}, Antonio and Copeland, {Larry J}",

year = "2019",

month = sep,

doi = "10.1136/ijgc-2019-000441",

language = "English",

volume = "29",

pages = "1094--1097",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

TY - JOUR

T1 - Joint ENGOT and GOG Foundation requirements for trials with industry partners

AU - European Network of Gynaecological Oncological Trial Groups (ENGOT) and The GOG Foundation, Inc

AU - Vergote, Ignace

AU - Coleman, Robert L

AU - Pignata, Sandro

AU - Bookman, Michael A

AU - Marth, Christian

AU - Herzog, Thomas J

AU - Gonzalez Martin, Antonio

AU - Copeland, Larry J

PY - 2019/9

Y1 - 2019/9

KW - Biomedical Research/standards

KW - Clinical Trials as Topic/economics

KW - Drug Industry/economics

KW - Female

KW - Genital Neoplasms, Female/drug therapy

KW - Gynecology/economics

KW - Humans

KW - Industry/economics

KW - Medical Oncology/economics

U2 - 10.1136/ijgc-2019-000441

DO - 10.1136/ijgc-2019-000441

M3 - Article

C2 - 31320391

SN - 1048-891X

VL - 29

SP - 1094

EP - 1097

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

IS - 7

ER -